Virani Shafique

Empresas donde Virani Shafique ha operado

• RECURSION PHARMACEUTICALS, INC.85 ops. · $5.2M · Jan 18, 2024

Historial de resultados de Virani Shafique

Historial insuficiente para un historial de resultados estadístico (menos de 5 compras en el mercado).

Historial de operaciones de Virani Shafique

Co-iniciados de Virani Shafique

• Bogue ZacharyRECURSION PHARMACEUTICALS, INC.
• Borgeson BlakeRECURSION PHARMACEUTICALS, INC.
• Bumpus NamandjeRECURSION PHARMACEUTICALS, INC.
• Burrell Terry-AnnRECURSION PHARMACEUTICALS, INC.
• CHAVEZ R. MARTINRECURSION PHARMACEUTICALS, INC.
• Dar ZavainRECURSION PHARMACEUTICALS, INC.
• Data Collective IV GP, LLCRECURSION PHARMACEUTICALS, INC.
• Data Collective IV, L.P.RECURSION PHARMACEUTICALS, INC.
• DCVC Opportunity Fund II GP, LLCRECURSION PHARMACEUTICALS, INC.
• DCVC Opportunity Fund II, L.P.RECURSION PHARMACEUTICALS, INC.
• DCVC V GP, LLCRECURSION PHARMACEUTICALS, INC.
• DCVC V, L.P.RECURSION PHARMACEUTICALS, INC.
• Doyle RamonaRECURSION PHARMACEUTICALS, INC.
• Gibson ChristopherRECURSION PHARMACEUTICALS, INC.
• Hallett DavidRECURSION PHARMACEUTICALS, INC.
• Hebert PeterRECURSION PHARMACEUTICALS, INC.
• HERSHBERG ROBERTRECURSION PHARMACEUTICALS, INC.
• Khan NajatRECURSION PHARMACEUTICALS, INC.
• Larson Tina MarriottRECURSION PHARMACEUTICALS, INC.
• Li Dean YRECURSION PHARMACEUTICALS, INC.
• Lux Co-Invest Opportunities, L.P.RECURSION PHARMACEUTICALS, INC.
• Lux Co-Invest Partners, LLCRECURSION PHARMACEUTICALS, INC.
• Lux Venture Partners IV, LLCRECURSION PHARMACEUTICALS, INC.
• Lux Ventures IV, L.P.RECURSION PHARMACEUTICALS, INC.
• Mauro David JRECURSION PHARMACEUTICALS, INC.
• MIC Capital Management UK LLPRECURSION PHARMACEUTICALS, INC.
• MIC Capital Partners (Public) Parallel Cayman, LPRECURSION PHARMACEUTICALS, INC.
• MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLCRECURSION PHARMACEUTICALS, INC.
• Michor FranziskaRECURSION PHARMACEUTICALS, INC.
• MUBADALA DEVELOPMENT CO PJSCRECURSION PHARMACEUTICALS, INC.
• Mubadala Investment Co PJSCRECURSION PHARMACEUTICALS, INC.